Together, these findings indicate that metabolites available to the PPP are increased in the absence of SCoR2, consistent with inhibition of PKM2 by S-nitrosylation (Fig. 3B) (as observed in multiple tissues (33,43) and known to be protective in the setting of ischemia (24)). This evidence concerns the gene PKM and ischemia.